<?xml version="1.0" encoding="UTF-8"?>
<ref id="B25">
 <label>25.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Fidock</surname>
    <given-names>DA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Rosenthal</surname>
    <given-names>PJ</given-names>
   </name>, 
   <name name-style="western">
    <surname>Croft</surname>
    <given-names>SL</given-names>
   </name>, 
   <name name-style="western">
    <surname>Brun</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Nwaka</surname>
    <given-names>S</given-names>
   </name>
  </person-group>
  <year>2004</year>
  <article-title>Antimalarial drug discovery: efficacy models for compound screening</article-title>. 
  <source>Nat Rev Drug Discov</source>
  <volume>3</volume>:
  <fpage>509</fpage>â€“
  <lpage>520</lpage>. doi:
  <pub-id pub-id-type="doi">10.1038/nrd1416</pub-id>.
  <pub-id pub-id-type="pmid">15173840</pub-id>
 </mixed-citation>
</ref>
